Artificial antibody delivers nanoparticles to tumors (News-Medical-Net)

Monday, January 19, 2009 | Technology

Antibodies that target epidermal growth factor receptor (EGFR) have proven themselves as potent anticancer drugs. Now, a team of investigators led by Shuming Nie, Ph.D., and Lily Yang, Ph.D., both at the Emory University School of Medicine and members of the Emory-Georgia Tech Nanotechnology Center for Personalized and Predictive Oncology, is aiming to capitalize on this targeting ability, using …
(get the story…)

Tags: , , , , , , , , , ,

ADVERTISEMENT / VIDEO